Comparative Effectiveness of Regimens for Drug-Susceptible Tuberculous Meningitis in Children and Adolescents: A Systematic Review and Aggregate-Level Data Meta-Analysis

BACKGROUND: Before August 2021, the only regimen recommended by the World Health Organization (WHO) to treat pediatric drug-susceptible tuberculous meningitis was a 12-month regimen consisting of isoniazid, rifampicin, ethambutol, and pyrazinamide (2HRZE/10HR). The comparative effectiveness of short...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulis, Giorgia, Tavaziva, Gamuchirai, Gore, Genevieve, Benedetti, Andrea, Solomons, Regan, van Toorn, Ronald, Thee, Stephanie, Day, Jeremy, Verkuijl, Sabine, Brands, Annemieke, Viney, Kerri, Masini, Tiziana, Ahmad Khan, Faiz, Chiang, Silvia S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167638/
https://www.ncbi.nlm.nih.gov/pubmed/35673608
http://dx.doi.org/10.1093/ofid/ofac108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167638/
https://www.ncbi.nlm.nih.gov/pubmed/35673608
http://dx.doi.org/10.1093/ofid/ofac108

Ejemplares similares